XML 31 R20.htm IDEA: XBRL DOCUMENT

Note 12 - Stock-based Compensation

9 Months Ended

Sep. 30, 2024

Notes to Financial Statements

Share-Based Payment Arrangement [Text Block]

NOTE 12 – STOCK-BASED COMPENSATION

Stock Options and Restricted Stock

On May 17, 2018, the shareholders of FS Bancorp approved the 2018 Equity Incentive Plan (the “2018 Plan”) that authorized 1.3 million shares of the Company’s common stock to be awarded. The 2018 Plan provides for the grant of incentive stock options, nonqualified stock options, and up to 326,000 shares as restricted stock awards (“RSAs”) to directors, emeritus directors, officers, employees or advisory directors of the Company. At September 30, 2024, there were 190,432 stock option awards and 38,372 RSAs available for future grants under the 2018 Plan.

Total share-based compensation expense was $464,000 and $1.2 million for the three and nine months ended September 30, 2024, respectively, and $590,000 and $1.6 million for the three and nine months ended September 30, 2023, respectively.

Stock Options

The 2018 Plan consists of stock option awards that may be granted as incentive stock options or nonqualified stock options. Stock option awards generally vest over a one-year and two-year period for independent directors or over a five-year period for employees and officers with 20% vesting on the anniversary date of each grant date as long as the award recipient remains in service to the Company. The options are exercisable after vesting for up to the remaining term of the original grant. The maximum term of the options granted is 10 years. Any unexercised stock options will expire 10 years after the grant date or sooner in the event of the award recipient’s termination of service with the Company or the Bank. The fair value of each stock option award is estimated on the grant date using a Black-Scholes Option pricing model that uses the following assumptions.

The fair value of options granted was determined using the following weighted-average assumptions as of the grant date for the periods indicated:

		September 30,			December 31,
		2024			2023
Dividend yield			2.57%			3.25%
Expected volatility			29.55%			28.24%
Risk-free interest rate			3.82%			4.35%
Expected term in years			6.3			6.5
Weighted-average grant date fair value per option granted		$	11.36		$	7.61

The dividend yield is based on the current quarterly dividend in effect at the time of the grant. The historical volatility of the Company's stock price over a specified period of time is used for the expected volatility. The Company bases the risk-free interest rate on the comparable U.S. Treasury rate for the discount rate associated with the stock in effect on the date of the grant. The Company elected to use Staff Accounting Bulletin 107, simplified expected term calculation for the “Share-Based Payments” method permitted by the SEC to calculate the expected term. This method uses the vesting term of an option along with the contractual term, setting the expected life at 5.5 years for one-year vesting, 5.75 years for two-year vesting, and 6.5 years for five-year vesting.

The following table presents a summary of the Company’s stock option awards during the dates indicated (shown as actual):

										Weighted-Average
						Weighted-				Remaining
						Average				Contractual Term In				Aggregate
		Shares				Exercise Price				Years				Intrinsic Value
Outstanding at January 1, 2024			662,279			$	28.12				6.69			$	5,852,975
Granted			75,100			$	41.98				9.87				—
Less exercised			141,878			$	21.88				—			$	3,042,273
Less forfeited			12,000				30.73				—				—
Outstanding at September 30, 2024			583,501			$	31.37				6.75			$	7,655,780

Expected to vest, assuming a 0.31% annual forfeiture rate at September 30, 2024 (1)			568,654			$	31.28				6.70			$	7,513,895

Exercisable at September 30, 2024			340,743			$	29.47				5.55			$	5,119,461

(1)

Forfeiture rate has been calculated and estimated, based on historical employment data, to assume a forfeiture of 3.1% of the options over 10 years.

At September 30, 2024, there was $2.1 million of total unrecognized compensation cost related to nonvested stock options granted under the 2018 Plan. The cost is expected to be recognized over the remaining weighted-average vesting period of 2.1 years.

Restricted Stock Awards

The RSAs’ fair value is equal to the value of the market price of FS Bancorp’s common stock on the grant date and compensation expense is recognized over the vesting period of the awards based on the fair value of the restricted stock. Shares granted under the 2018 Plan generally vest over a one-year or two-year period for independent directors and a five-year period for employees and officers beginning on the grant date. Any nonvested RSAs will be forfeited in the event of the award recipient’s termination of service with the Company or the Bank.

The following table presents a summary of the Company’s nonvested awards during the dates indicated (shown as actual):

						Weighted-Average
						Grant-Date Fair Value
Nonvested Shares		Shares				Per Share
Nonvested at January 1, 2024			102,144			$	29.61
Granted			42,250				41.98
Less vested			36,581				28.19
Less forfeited			4,000				30.73
Nonvested at September 30, 2024			103,813			$	35.10

At September 30, 2024, there was $3.5 million of total unrecognized compensation cost related to nonvested shares granted under the 2018 Plan as RSAs. The cost is expected to be recognized over the remaining weighted-average vesting period of 2.1 years.